Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > No More Equity Issues

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Dec 10, 2021 12:21pm

101 Views

Post# 34219005

RE:RE:RE:No More Equity Issues

PR and IR work when you're selling sizzle. They aren't going to stick their necks out any farther while trying to please the FDA.

They just need to deliver on the trial enrollements and the rest will come.

If you look back to 2016 the price ran from .74 to 1.80 over 5 mos as the trial was winding down.

A DIMI/ DaVita trial partnership would be a sweet signal/ kick in the asss too.

<< Previous

Bullboard Posts

Next >>

dynaCERT leans into global growth with new HydraGEN orders